New long Covid study
Swiss PharmaCan AG of Frauenfeld, Switzerland, together with two international partners – Glow LifeTech of Canada and MCC Pharmaceuticals of Australia – has initiated a clinical study to confirm the efficacy of ArtemiC Support in patients with Long Covid. This is a follow-up to the successful completion of the Phase II clinical trial with 50 patients. The current study involves 150 adults with Long Covid symptoms. Significant improvement is expected to occur after only a few days.